By proceeding, you agree to our Terms of Use and Privacy Policy.
Goodwin Biotechnology, Inc.
21-23 February 2023
With numerous next-generation conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads a
Event Ended
USA
Paid
Boston